{{Rsnum
|rsid=7079
|Gene=AGT
|Chromosome=1
|position=230702585
|Orientation=minus
|GMAF=0.2025
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=AGT
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 12.4 | 40.7 | 46.9
| HCB | 2.2 | 26.3 | 71.5
| JPT | 0.9 | 21.2 | 77.9
| YRI | 0.0 | 12.2 | 87.8
| ASW | 0.0 | 19.3 | 80.7
| CHB | 2.2 | 26.3 | 71.5
| CHD | 3.7 | 27.8 | 68.5
| GIH | 5.9 | 37.6 | 56.4
| LWK | 0.9 | 16.4 | 82.7
| MEX | 5.2 | 22.4 | 72.4
| MKK | 0.6 | 21.8 | 77.6
| TSI | 12.9 | 43.6 | 43.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=21261619
|Title=Genetic variation in renin predicts the effects of thiazide diuretics
}}

{{PMID Auto
|PMID=21988197
|Title=Angiotensinogen gene haplotype is associated with the prevalence of Japanese non-alcoholic steatohepatitis
}}

{{PMID Auto
|PMID=17261659
|Title=Association between angiotensinogen, angiotensin II receptor genes, and blood pressure response to an angiotensin-converting enzyme inhibitor.
}}

{{PMID Auto
|PMID=21562941
|Title=Do genetic variants of the Renin-Angiotensin system predict blood pressure response to Renin-Angiotensin system-blocking drugs?: a systematic review of pharmacogenomics in the Renin-Angiotensin system.
|OA=1
}}

{{PMID Auto
|PMID=23943853
|Title=Human Angiotensinogen +11525 C/A Polymorphism Modulates Its Gene Expression Through MicroRNA Binding
}}

{{PMID Auto
|PMID=22858200
|Title=Angiotensinogen gene polymorphisms and food-intake behavior in young, normal female subjects in Japan.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}